Skip to main content

Shana Kelley’s by Jef Ekins/University of Toronto

Innovators at Work is a contest to recognize talented people who not only have great ideas but also turn them into reality through their drive and their actions. You can nominate an Innovator here.

Among the many talents that Shana Kelley possesses as an innovator, there's a simple idea: To find out something, go to it, don't wait for it to come to you.

In Dr. Kelley's case, "it" includes diagnosing some of the world's most deadly diseases. The University of Toronto chemistry professor is co-founder of Xagenic, a startup that has developed a fast, cost-effective way for molecular testing in the field instead of the lab.

Story continues below advertisement

Xagenic's lab-free molecular diagnostic platform is designed to provide test results for patients on site within 20 minutes. The technology could be used to diagnose cancer and infectious diseases and for drug delivery.

The aim is to empower clinicians to make treatment decisions for their patients the first time they see them, dramatically improving care, reducing health-care costs – and saving lives. Right now, most diagnostic testing is done in centralized labs and can take weeks or months.

Dr. Kelley and her team developed a hand-held device in Toronto, with seed funding from MaRS innovation and other local organizations. The team has insisted on keeping the company in downtown Toronto, to stay closer to both investors and the university community.

In three years, the company has grown to 30 employees, and has raised more than $30-million from Canadian, U.S. and European backers.

"Bringing a new technology to market is a huge challenge – and many have failed trying," she wrote on her blog recently for the Ontario Ministry of Research and Innovation.

"So you have to be prepared for skeptics. Believing 100 per cent in what you're doing … is key. As is keeping the faith when confronted with skeptics, or all the investors that will tell you, 'No.' You need to believe strongly enough in what you are doing to weather the rejection or pessimism you will face along the way."

Believing in what she's doing is nothing new for Dr. Kelley. Just two years after joining the U of T, she became director of biomolecular sciences, and she invented the first electronic chip that could sense molecular disease markers.

Story continues below advertisement

Dr. Kelley also co-founded GeneOhm Sciences, a nanotechnology firm set up to make products to prevent hospital-acquired infections. She has been awarded the prestigious Steacie Prize, given to promising young scientists and engineers, and was named one of Canada's "Top 40 under 40" and a "Top 100 Innovator" by MIT's Technology Review.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter